You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rifampicin

Showing 26 - 50 of 481
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Subject Trial in Groningen (Saline, ACT-246475, Rifampicin)

Completed
  • Healthy Subject
  • Groningen, Netherlands
    QPS Netherlands B.V.
Jan 18, 2022

Tuberculosis, Pulmonary Trial in Cape Town (Sanfetrinem Cilexetil, Amoxicillin/clavulanic acid, Rifampicin)

Recruiting
  • Tuberculosis, Pulmonary
  • Sanfetrinem Cilexetil
  • +2 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
May 19, 2022

Solid Tumors Trial in Canada, United Kingdom (cediranib)

Active, not recruiting
  • Solid Tumors
  • Edmonton, Alberta, Canada
  • +4 more
Sep 20, 2022

Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis Trial in Worldwide (Sutezolid, Rifampicin, Isoniazid)

Recruiting
  • Pulmonary Tuberculosis
  • Other Specified Pulmonary Tuberculosis
  • Lambaréné, Gabon
  • +7 more
Apr 17, 2023

Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB) Trial in Cape Town (BVL-GSK098 9mg, Ethionamide 250mg,

Not yet recruiting
  • Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)
  • BVL-GSK098 9mg
  • +3 more
  • Cape Town, Western Cape, South Africa
    TASK Clinical Research Centre
Jul 26, 2022

Healthy Subjects Trial in Hangzhou (SHR6390 tablet single oral dose of SHR6390 or co-administered with rifampicin)

Completed
  • Healthy Subjects
  • SHR6390 tablet single oral dose of SHR6390 or co-administered with rifampicin
  • Hangzhou, Zhejiang, China
    Zhejiang provincial people's hospital
Oct 11, 2021

Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 tablets
  • +2 more
  • Jinan, Shandong, China
    Shandong Provincial Hospital
Aug 30, 2023

Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis Trial in Port Elizabeth (Bedaquiline Oral Tablet, Linezolid

Active, not recruiting
  • Tuberculosis
  • +4 more
  • Bedaquiline Oral Tablet
  • +7 more
  • Port Elizabeth, Eastern Cape, South Africa
  • +1 more
Oct 20, 2022

Disseminated Tuberculosis, HIV Trial in Cape Town (Rifampin, Levofloxacin, Rifampicin, Pyrazinamide, Ethambutol and Isoniazid)

Recruiting
  • Disseminated Tuberculosis
  • HIV
  • Cape Town, Western Cape, South Africa
  • +1 more
Mar 30, 2022

Multidrug-resistant Tuberculosis, Pulmonary Tuberculosis, Tuberculosis Trial in Niamey (6EH³R³Z, 6EHRZ)

Recruiting
  • Multidrug-resistant Tuberculosis
  • +3 more
  • Niamey, Niger
    Damien Foundation
Oct 29, 2021

Healthy Subjects Trial in Beijing (SKLB1028, Itraconazole, Gemfibrozil)

Active, not recruiting
  • Healthy Subjects
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Sep 26, 2021

Tuberculosis, Pulmonary Trial in Linköping (rifampicin, pyrazinamide, HRZE)

Recruiting
  • Tuberculosis, Pulmonary
  • rifampicin
  • +3 more
  • Linköping, Sweden
    Linköping University Hospital
Aug 19, 2021

Pediatric HIV Infection, Tuberculosis Infection Trial (rifampicin)

Not yet recruiting
  • Pediatric HIV Infection
  • Tuberculosis Infection
  • rifampicin
  • (no location specified)
Sep 26, 2021

Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)

Not yet recruiting
  • Pulmonary Tuberculosis
  • Rifampicin-resistant Tuberculosis
  • Beijing, Beijing, China
  • +37 more
Oct 11, 2023

Tuberculosis Trial in Cape Town (phenotyping cocktail, rifampicin)

Completed
  • Tuberculosis
  • phenotyping cocktail
  • rifampicin
  • Cape Town, South Africa
  • +1 more
Aug 16, 2021

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Trial in Tempe (CCX168, Midazolam, Celecoxib)

Completed
  • Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
  • Tempe, Arizona
    Celerion
Aug 15, 2023

Pulmonary Tuberculosis Trial (Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS), Pretomanid, Bedaquiline, OPC-167832, and

Not yet recruiting
  • Pulmonary Tuberculosis
  • Delamanid, Bedaquiline, OPC-167832, and Sutezolid (DBOS)
  • +3 more
  • (no location specified)
Jul 25, 2023

Leprosy Trial in Anjouan, Mohéli, Miandrivazo (Rifampicin)

Active, not recruiting
  • Leprosy
  • Rifampicin
  • Anjouan, Comoros
  • +2 more
Sep 20, 2022

Solid Tumors Trial in Bruxelles, Wilrijk (BI 907828, Rifampicin)

Recruiting
  • Solid Tumors
  • BI 907828
  • Rifampicin
  • Bruxelles, Belgium
  • +4 more
Jan 9, 2023

Clinical Trial Trial in Moshi (Evaluation of high dose rifampicin in children)

Recruiting
  • Clinical Trial
  • Evaluation of high dose rifampicin in children
  • Moshi, Kilimanjaro, Tanzania
  • +1 more
Sep 13, 2021

Latent Tuberculosis, Kidney Failure Trial (Rifampicin plus Isoniazid, Rifapentine plus Isoniazid, Rifampicin alone)

Not yet recruiting
  • Latent Tuberculosis
  • Kidney Failure
  • Rifampicin plus Isoniazid
  • +2 more
  • (no location specified)
Aug 24, 2021

Endocarditis Infective Trial in Barcelona (Cefaclor, Ciprofloxacin Tablets, Ciprofloxacin Injection)

Not yet recruiting
  • Endocarditis Infective
  • Barcelona, Spain
    Hospital Clinic i Provincial de Barcelona
May 26, 2022

Latent Tuberculosis, Diabetes, Type 2 Trial in Copenhagen (Rifampicin 300 Mg Oral Capsule, Isoniazid 300 Mg ORAL TABLET)

Recruiting
  • Latent Tuberculosis
  • Diabetes Mellitus, Type 2
  • Rifampicin 300 Mg Oral Capsule
  • Isoniazid 300 Mg ORAL TABLET
  • Copenhagen, Denmark
    Herlev-Gentofte Hospital
Aug 3, 2022

NSCLC Trial in Shanghai (BPI-7711, Itraconazole, Rifampicin)

Completed
  • NSCLC
  • Shanghai, China
    Shanghai Xuhui Central Hospital
Apr 21, 2021

Healthy Trial in Bengbu (XZP-3287 combined with clarithromycin, XZP-3287 combined with rifampicin)

Recruiting
  • Healthy
  • XZP-3287 combined with clarithromycin
  • XZP-3287 combined with rifampicin
  • Bengbu, Anhui, China
    The First Affiliated Hospital of Bengbu Medical College
Jul 20, 2021